BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29781560)

  • 1. Conditioned Reward of Opioids, but not Psychostimulants, is Impaired in GABA-A Receptor δ Subunit Knockout Mice.
    Siivonen MS; de Miguel E; Aaltio J; Manner AK; Vahermo M; Yli-Kauhaluoma J; Linden AM; Aitta-Aho T; Korpi ER
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):558-566. PubMed ID: 29781560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAA receptors in VTA mediate the morphine-induced release of ascorbic acid in rat nucleus accumbens.
    Sun JY; Yang JY; Wang F; Hou Y; Dong YX; Wu CF
    Brain Res; 2011 Jan; 1368():52-8. PubMed ID: 20965157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurosteroid Agonist at GABAA receptor induces persistent neuroplasticity in VTA dopamine neurons.
    Vashchinkina E; Manner AK; Vekovischeva O; den Hollander B; Uusi-Oukari M; Aitta-Aho T; Korpi ER
    Neuropsychopharmacology; 2014 Feb; 39(3):727-37. PubMed ID: 24077066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons.
    Vashchinkina E; Panhelainen A; Vekovischeva OY; Aitta-aho T; Ebert B; Ator NA; Korpi ER
    J Neurosci; 2012 Apr; 32(15):5310-20. PubMed ID: 22496576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids.
    Porter-Stransky KA; Petko AK; Karne SL; Liles LC; Urs NM; Caron MG; Paladini CA; Weinshenker D
    Addict Biol; 2020 Nov; 25(6):e12823. PubMed ID: 31441201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine-induced molecular alterations are modulated by GABA
    Varani AP; Pedrón VT; Aon AJ; Höcht C; Acosta GB; Bettler B; Balerio GN
    Addict Biol; 2018 Jan; 23(1):230-246. PubMed ID: 28419642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
    Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
    Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
    Wang X; Northcutt AL; Cochran TA; Zhang X; Fabisiak TJ; Haas ME; Amat J; Li H; Rice KC; Maier SF; Bachtell RK; Hutchinson MR; Watkins LR
    ACS Chem Neurosci; 2019 Aug; 10(8):3622-3634. PubMed ID: 31282647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous histamine inhibits the development of morphine-induced conditioned place preference.
    Gong YX; Lv M; Zhu YP; Zhu YY; Wei EQ; Shi H; Zeng QL; Chen Z
    Acta Pharmacol Sin; 2007 Jan; 28(1):10-8. PubMed ID: 17184577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α6 subunit-containing nicotinic receptors mediate low-dose ethanol effects on ventral tegmental area neurons and ethanol reward.
    Steffensen SC; Shin SI; Nelson AC; Pistorius SS; Williams SB; Woodward TJ; Park HJ; Friend L; Gao M; Gao F; Taylor DH; Foster Olive M; Edwards JG; Sudweeks SN; Buhlman LM; Michael McIntosh J; Wu J
    Addict Biol; 2018 Sep; 23(5):1079-1093. PubMed ID: 28901722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV1 modulates morphine-induced conditioned place preference via p38 MAPK in the nucleus accumbens.
    Hong SI; Nguyen TL; Ma SX; Kim HC; Lee SY; Jang CG
    Behav Brain Res; 2017 Sep; 334():26-33. PubMed ID: 28734766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of GABAergic receptors located in the ventral tegmental area on the expression of morphine-induced conditioned place preference in rat.
    Sahraei H; Amiri YA; Haeri-Rohani A; Sepehri H; Salimi SH; Pourmotabbed A; Ghoshooni H; Zahirodin A; Zardooz H
    Eur J Pharmacol; 2005 Nov; 524(1-3):95-101. PubMed ID: 16253224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area.
    Madhavan A; Bonci A; Whistler JL
    J Neurosci; 2010 Oct; 30(42):14029-35. PubMed ID: 20962224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
    Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
    Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of music in morphine rewarding effects in mice using conditioned place preference method.
    Tavakoli F; Hoseini SE; Mokhtari M; Vahdati A; Razmi N; Vessal M
    Neuro Endocrinol Lett; 2012; 33(7):709-12. PubMed ID: 23391882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the role of muscarinic M
    Li X; Zheng Y; Zhao X; Cui R; Li X
    Neurosci Lett; 2022 Aug; 786():136774. PubMed ID: 35809878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition.
    Koo JW; Lobo MK; Chaudhury D; Labonté B; Friedman A; Heller E; Peña CJ; Han MH; Nestler EJ
    Neuropsychopharmacology; 2014 Oct; 39(11):2646-53. PubMed ID: 24853771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model.
    Rashidy-Pour A; Pahlevani P; Vaziri A; Shaigani P; Zarepour L; Vafaei AA; Haghparast A
    Behav Brain Res; 2013 Jun; 247():259-67. PubMed ID: 23511249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats.
    Chen SL; Hsu KY; Huang EY; Lu RB; Tao PL
    Drug Alcohol Depend; 2011 Sep; 117(2-3):164-9. PubMed ID: 21320758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.